ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Type 1 Diabetes (T1D) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0P11659
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Type 1 Diabetes T1D Market Research Report 2022
BUY CHAPTERS

Global Type 1 Diabetes (T1D) Market Research Report 2025

Code: QYRE-Auto-0P11659
Report
September 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon Ltd.
Astellas
Janssen
Bristol–Myers Squibb
Lexicon
Sanofi

Type 1 Diabetes (T1D) Market Size

The global market for Type 1 Diabetes (T1D) was valued at US$ 2135 million in the year 2024 and is projected to reach a revised size of US$ 2912 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Type 1 Diabetes (T1D) Market

Type 1 Diabetes (T1D) Market

Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Type 1 Diabetes (T1D), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 1 Diabetes (T1D).
The Type 1 Diabetes (T1D) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Type 1 Diabetes (T1D) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 1 Diabetes (T1D) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Type 1 Diabetes (T1D) Market Report

Report Metric Details
Report Name Type 1 Diabetes (T1D) Market
Accounted market size in year US$ 2135 million
Forecasted market size in 2031 US$ 2912 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Rapid Acting Insulin Analogs
  • Long Acting Insulin Analogs
  • Premix Insulin Analogs
Segment by Application
  • Children
  • Adults
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Sanofi, Eli Lilly, Merck, Boehringer Ingelheim, Samsung Bioepis, Biocon, Astellas, Janssen, Bristol-Myers Squibb, Lexicon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Type 1 Diabetes (T1D) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Type 1 Diabetes (T1D) Market growing?

Ans: The Type 1 Diabetes (T1D) Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Type 1 Diabetes (T1D) Market size in 2031?

Ans: The Type 1 Diabetes (T1D) Market size in 2031 will be US$ 2912 million.

Who are the main players in the Type 1 Diabetes (T1D) Market report?

Ans: The main players in the Type 1 Diabetes (T1D) Market are Novo Nordisk, Sanofi, Eli Lilly, Merck, Boehringer Ingelheim, Samsung Bioepis, Biocon, Astellas, Janssen, Bristol-Myers Squibb, Lexicon

What are the Application segmentation covered in the Type 1 Diabetes (T1D) Market report?

Ans: The Applications covered in the Type 1 Diabetes (T1D) Market report are Children, Adults

What are the Type segmentation covered in the Type 1 Diabetes (T1D) Market report?

Ans: The Types covered in the Type 1 Diabetes (T1D) Market report are Rapid Acting Insulin Analogs, Long Acting Insulin Analogs, Premix Insulin Analogs

1 Type 1 Diabetes (T1D) Market Overview
1.1 Product Definition
1.2 Type 1 Diabetes (T1D) by Type
1.2.1 Global Type 1 Diabetes (T1D) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rapid Acting Insulin Analogs
1.2.3 Long Acting Insulin Analogs
1.2.4 Premix Insulin Analogs
1.3 Type 1 Diabetes (T1D) by Application
1.3.1 Global Type 1 Diabetes (T1D) Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adults
1.4 Global Type 1 Diabetes (T1D) Market Size Estimates and Forecasts
1.4.1 Global Type 1 Diabetes (T1D) Revenue 2020-2031
1.4.2 Global Type 1 Diabetes (T1D) Sales 2020-2031
1.4.3 Global Type 1 Diabetes (T1D) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Type 1 Diabetes (T1D) Market Competition by Manufacturers
2.1 Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Type 1 Diabetes (T1D) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Type 1 Diabetes (T1D), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Type 1 Diabetes (T1D), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Type 1 Diabetes (T1D), Product Type & Application
2.7 Global Key Manufacturers of Type 1 Diabetes (T1D), Date of Enter into This Industry
2.8 Global Type 1 Diabetes (T1D) Market Competitive Situation and Trends
2.8.1 Global Type 1 Diabetes (T1D) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Type 1 Diabetes (T1D) Players Market Share by Revenue
2.8.3 Global Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Type 1 Diabetes (T1D) Market Scenario by Region
3.1 Global Type 1 Diabetes (T1D) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Type 1 Diabetes (T1D) Sales by Region: 2020-2031
3.2.1 Global Type 1 Diabetes (T1D) Sales by Region: 2020-2025
3.2.2 Global Type 1 Diabetes (T1D) Sales by Region: 2026-2031
3.3 Global Type 1 Diabetes (T1D) Revenue by Region: 2020-2031
3.3.1 Global Type 1 Diabetes (T1D) Revenue by Region: 2020-2025
3.3.2 Global Type 1 Diabetes (T1D) Revenue by Region: 2026-2031
3.4 North America Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.4.1 North America Type 1 Diabetes (T1D) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Type 1 Diabetes (T1D) Sales by Country (2020-2031)
3.4.3 North America Type 1 Diabetes (T1D) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.5.1 Europe Type 1 Diabetes (T1D) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Type 1 Diabetes (T1D) Sales by Country (2020-2031)
3.5.3 Europe Type 1 Diabetes (T1D) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Type 1 Diabetes (T1D) Market Facts & Figures by Region
3.6.1 Asia Pacific Type 1 Diabetes (T1D) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Type 1 Diabetes (T1D) Sales by Region (2020-2031)
3.6.3 Asia Pacific Type 1 Diabetes (T1D) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.7.1 Latin America Type 1 Diabetes (T1D) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Type 1 Diabetes (T1D) Sales by Country (2020-2031)
3.7.3 Latin America Type 1 Diabetes (T1D) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.8.1 Middle East and Africa Type 1 Diabetes (T1D) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Type 1 Diabetes (T1D) Sales by Type (2020-2031)
4.1.1 Global Type 1 Diabetes (T1D) Sales by Type (2020-2025)
4.1.2 Global Type 1 Diabetes (T1D) Sales by Type (2026-2031)
4.1.3 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2020-2031)
4.2 Global Type 1 Diabetes (T1D) Revenue by Type (2020-2031)
4.2.1 Global Type 1 Diabetes (T1D) Revenue by Type (2020-2025)
4.2.2 Global Type 1 Diabetes (T1D) Revenue by Type (2026-2031)
4.2.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2020-2031)
4.3 Global Type 1 Diabetes (T1D) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Type 1 Diabetes (T1D) Sales by Application (2020-2031)
5.1.1 Global Type 1 Diabetes (T1D) Sales by Application (2020-2025)
5.1.2 Global Type 1 Diabetes (T1D) Sales by Application (2026-2031)
5.1.3 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2020-2031)
5.2 Global Type 1 Diabetes (T1D) Revenue by Application (2020-2031)
5.2.1 Global Type 1 Diabetes (T1D) Revenue by Application (2020-2025)
5.2.2 Global Type 1 Diabetes (T1D) Revenue by Application (2026-2031)
5.2.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2020-2031)
5.3 Global Type 1 Diabetes (T1D) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Type 1 Diabetes (T1D) Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Type 1 Diabetes (T1D) Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Company Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Samsung Bioepis
6.6.1 Samsung Bioepis Company Information
6.6.2 Samsung Bioepis Description and Business Overview
6.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio
6.6.5 Samsung Bioepis Recent Developments/Updates
6.7 Biocon
6.7.1 Biocon Company Information
6.7.2 Biocon Description and Business Overview
6.7.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biocon Type 1 Diabetes (T1D) Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Astellas
6.8.1 Astellas Company Information
6.8.2 Astellas Description and Business Overview
6.8.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Astellas Type 1 Diabetes (T1D) Product Portfolio
6.8.5 Astellas Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Company Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Janssen Type 1 Diabetes (T1D) Product Portfolio
6.9.5 Janssen Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Company Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Lexicon
6.11.1 Lexicon Company Information
6.11.2 Lexicon Description and Business Overview
6.11.3 Lexicon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lexicon Type 1 Diabetes (T1D) Product Portfolio
6.11.5 Lexicon Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Company Information
6.12.2 Sanofi Description and Business Overview
6.12.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Type 1 Diabetes (T1D) Industry Chain Analysis
7.2 Type 1 Diabetes (T1D) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Type 1 Diabetes (T1D) Production Mode & Process Analysis
7.4 Type 1 Diabetes (T1D) Sales and Marketing
7.4.1 Type 1 Diabetes (T1D) Sales Channels
7.4.2 Type 1 Diabetes (T1D) Distributors
7.5 Type 1 Diabetes (T1D) Customer Analysis
8 Type 1 Diabetes (T1D) Market Dynamics
8.1 Type 1 Diabetes (T1D) Industry Trends
8.2 Type 1 Diabetes (T1D) Market Drivers
8.3 Type 1 Diabetes (T1D) Market Challenges
8.4 Type 1 Diabetes (T1D) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon Ltd.
Astellas
Janssen
Bristol–Myers Squibb
Lexicon
Sanofi
List of Tables
 Table 1. Global Type 1 Diabetes (T1D) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Type 1 Diabetes (T1D) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Type 1 Diabetes (T1D) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Type 1 Diabetes (T1D) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Type 1 Diabetes (T1D) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Type 1 Diabetes (T1D) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Type 1 Diabetes (T1D), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Type 1 Diabetes (T1D), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Type 1 Diabetes (T1D), Product Type & Application
 Table 12. Global Key Manufacturers of Type 1 Diabetes (T1D), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Type 1 Diabetes (T1D) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes (T1D) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Type 1 Diabetes (T1D) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Type 1 Diabetes (T1D) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2020-2025)
 Table 19. Global Type 1 Diabetes (T1D) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2026-2031)
 Table 21. Global Type 1 Diabetes (T1D) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2020-2025)
 Table 23. Global Type 1 Diabetes (T1D) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2026-2031)
 Table 25. North America Type 1 Diabetes (T1D) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Type 1 Diabetes (T1D) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Type 1 Diabetes (T1D) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Type 1 Diabetes (T1D) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Type 1 Diabetes (T1D) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Type 1 Diabetes (T1D) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Type 1 Diabetes (T1D) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Type 1 Diabetes (T1D) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Type 1 Diabetes (T1D) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Type 1 Diabetes (T1D) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Type 1 Diabetes (T1D) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Type 1 Diabetes (T1D) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Type 1 Diabetes (T1D) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Type 1 Diabetes (T1D) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Type 1 Diabetes (T1D) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Type 1 Diabetes (T1D) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Type 1 Diabetes (T1D) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Type 1 Diabetes (T1D) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Type 1 Diabetes (T1D) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Type 1 Diabetes (T1D) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Type 1 Diabetes (T1D) Sales (K Units) by Type (2020-2025)
 Table 51. Global Type 1 Diabetes (T1D) Sales (K Units) by Type (2026-2031)
 Table 52. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2020-2025)
 Table 53. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2026-2031)
 Table 54. Global Type 1 Diabetes (T1D) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Type 1 Diabetes (T1D) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2020-2025)
 Table 57. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2026-2031)
 Table 58. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Type 1 Diabetes (T1D) Sales (K Units) by Application (2020-2025)
 Table 61. Global Type 1 Diabetes (T1D) Sales (K Units) by Application (2026-2031)
 Table 62. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2020-2025)
 Table 63. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2026-2031)
 Table 64. Global Type 1 Diabetes (T1D) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Type 1 Diabetes (T1D) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2020-2025)
 Table 67. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2026-2031)
 Table 68. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Type 1 Diabetes (T1D) Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Type 1 Diabetes (T1D) Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Type 1 Diabetes (T1D) Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Type 1 Diabetes (T1D) Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Boehringer Ingelheim Company Information
 Table 91. Boehringer Ingelheim Description and Business Overview
 Table 92. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Boehringer Ingelheim Type 1 Diabetes (T1D) Product
 Table 94. Boehringer Ingelheim Recent Developments/Updates
 Table 95. Samsung Bioepis Company Information
 Table 96. Samsung Bioepis Description and Business Overview
 Table 97. Samsung Bioepis Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Samsung Bioepis Type 1 Diabetes (T1D) Product
 Table 99. Samsung Bioepis Recent Developments/Updates
 Table 100. Biocon Company Information
 Table 101. Biocon Description and Business Overview
 Table 102. Biocon Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Biocon Type 1 Diabetes (T1D) Product
 Table 104. Biocon Recent Developments/Updates
 Table 105. Astellas Company Information
 Table 106. Astellas Description and Business Overview
 Table 107. Astellas Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Astellas Type 1 Diabetes (T1D) Product
 Table 109. Astellas Recent Developments/Updates
 Table 110. Janssen Company Information
 Table 111. Janssen Description and Business Overview
 Table 112. Janssen Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Janssen Type 1 Diabetes (T1D) Product
 Table 114. Janssen Recent Developments/Updates
 Table 115. Bristol-Myers Squibb Company Information
 Table 116. Bristol-Myers Squibb Description and Business Overview
 Table 117. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product
 Table 119. Bristol-Myers Squibb Recent Developments/Updates
 Table 120. Lexicon Company Information
 Table 121. Lexicon Description and Business Overview
 Table 122. Lexicon Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Lexicon Type 1 Diabetes (T1D) Product
 Table 124. Lexicon Recent Developments/Updates
 Table 125. Sanofi Company Information
 Table 126. Sanofi Description and Business Overview
 Table 127. Sanofi Type 1 Diabetes (T1D) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Sanofi Type 1 Diabetes (T1D) Product
 Table 129. Sanofi Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Type 1 Diabetes (T1D) Distributors List
 Table 133. Type 1 Diabetes (T1D) Customers List
 Table 134. Type 1 Diabetes (T1D) Market Trends
 Table 135. Type 1 Diabetes (T1D) Market Drivers
 Table 136. Type 1 Diabetes (T1D) Market Challenges
 Table 137. Type 1 Diabetes (T1D) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Type 1 Diabetes (T1D)
 Figure 2. Global Type 1 Diabetes (T1D) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Type 1 Diabetes (T1D) Market Share by Type: 2024 & 2031
 Figure 4. Rapid Acting Insulin Analogs Product Picture
 Figure 5. Long Acting Insulin Analogs Product Picture
 Figure 6. Premix Insulin Analogs Product Picture
 Figure 7. Global Type 1 Diabetes (T1D) Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Type 1 Diabetes (T1D) Market Share by Application: 2024 & 2031
 Figure 9. Children
 Figure 10. Adults
 Figure 11. Global Type 1 Diabetes (T1D) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Type 1 Diabetes (T1D) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Type 1 Diabetes (T1D) Sales (2020-2031) & (K Units)
 Figure 14. Global Type 1 Diabetes (T1D) Average Price (USD/Unit) & (2020-2031)
 Figure 15. Type 1 Diabetes (T1D) Report Years Considered
 Figure 16. Type 1 Diabetes (T1D) Sales Share by Manufacturers in 2024
 Figure 17. Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Type 1 Diabetes (T1D) Players: Market Share by Revenue in Type 1 Diabetes (T1D) in 2024
 Figure 19. Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Type 1 Diabetes (T1D) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Type 1 Diabetes (T1D) Sales Market Share by Country (2020-2031)
 Figure 22. North America Type 1 Diabetes (T1D) Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Type 1 Diabetes (T1D) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Type 1 Diabetes (T1D) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Type 1 Diabetes (T1D) Revenue Market Share by Region (2020-2031)
 Figure 34. China Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Type 1 Diabetes (T1D) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Type 1 Diabetes (T1D) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Type 1 Diabetes (T1D) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Type 1 Diabetes (T1D) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Type 1 Diabetes (T1D) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Type 1 Diabetes (T1D) by Type (2020-2031)
 Figure 56. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Type 1 Diabetes (T1D) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Type 1 Diabetes (T1D) by Application (2020-2031)
 Figure 59. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Application (2020-2031)
 Figure 60. Type 1 Diabetes (T1D) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions